Macromolecular crowding modulates α-synuclein amyloid fiber growth. 2021

Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

The crowdedness of living cells, hundreds of milligrams per milliliter of macromolecules, may affect protein folding, function, and misfolding. Still, such processes are most often studied in dilute solutions in vitro. To assess consequences of the in vivo milieu, we here investigated the effects of macromolecular crowding on the amyloid fiber formation reaction of α-synuclein, the amyloidogenic protein in Parkinson's disease. For this, we performed spectroscopic experiments probing individual steps of the reaction as a function of the macromolecular crowding agent Ficoll70, which is an inert sucrose-based polymer that provides excluded-volume effects. The experiments were performed at neutral pH at quiescent conditions to avoid artifacts due to shaking and glass beads (typical conditions for α-synuclein), using amyloid fiber seeds to initiate reactions. We find that both primary nucleation and fiber elongation steps during α-synuclein amyloid formation are accelerated by the presence of 140 and 280 mg/mL Ficoll70. Moreover, in the presence of Ficoll70 at neutral pH, secondary nucleation appears favored, resulting in faster overall α-synuclein amyloid formation. In contrast, sucrose, a small-molecule osmolyte and building block of Ficoll70, slowed down α-synuclein amyloid formation. The ability of cell environments to modulate reaction kinetics to a large extent, such as severalfold faster individual steps in α-synuclein amyloid formation, is an important consideration for biochemical reactions in living systems.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D017510 Protein Folding Processes involved in the formation of TERTIARY PROTEIN STRUCTURE. Protein Folding, Globular,Folding, Globular Protein,Folding, Protein,Foldings, Globular Protein,Foldings, Protein,Globular Protein Folding,Globular Protein Foldings,Protein Foldings,Protein Foldings, Globular
D051844 alpha-Synuclein A synuclein that is a major component of LEWY BODIES and plays a role in SYNUCLEINOPATHIES, neurodegeneration and neuroprotection. Non-AB Component of AD Amyloid Protein,Non AB Component of AD Amyloid Protein,alpha Synuclein

Related Publications

Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
January 2017, Chemphyschem : a European journal of chemical physics and physical chemistry,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
July 2016, Biophysical journal,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
February 2016, The Journal of chemical physics,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
June 2023, Biophysical journal,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
February 2013, International journal of biological macromolecules,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
September 2016, Biophysical chemistry,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
January 2001, Methods in molecular medicine,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
April 2022, Nature physics,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
February 2006, Journal of molecular biology,
Istvan Horvath, and Ranjeet Kumar, and Pernilla Wittung-Stafshede
March 2020, ACS chemical neuroscience,
Copied contents to your clipboard!